| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |